Cellular Logistics and Allele Biotech, a company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers, have partnered, the company announced recently. The two…
Cellectar Biosciences has partnered with Meaningful Insights-BioTech Analytics (MiBA), a data subsidiary of American Oncology Network (AON), the organization announced today. According to a release, the partnership will look to…
Nimble Therapeutics and Genentech, a member of the Roche Group, have expanded their partnership, the company announced today. According to a release, the companies executed a license agreement for the…
NorthStar Medical Radioisotopes has expanded its strategic collaboration with Curadh, the organization announced today. According to a release, under the new agreement, NorthStar will manufacture and distribute patient doses for…
Cellectar Biosciences has expanded its licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for intellectual property that was the result of collaborative research conducted at the University of Wisconsin…
Exact Sciences has awarded $1.3 million to 23 organizations through its Funding Opportunities for Colorectal Screening Uptake Strategies (FOCUS) Program, the company announced today. According to a release, the FOCUS…
SHINE Technologies and Nucleus RadioPharma are partnering to advance radioligand cancer treatments, SHINE announced recently. “We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers…
Cellectar Biosciences is partnering with Florida Cancer Specialists & Research Institute (FCS) to advance patient care and further define the U.S. treatment landscape, the company announced today. According to a…
Stem Pharm announced recently that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to advance a groundbreaking model of Alzheimer’s…
SHINE Technologies has raised $70 million in additional funding to accelerate the commercialization of near-term applications of fusion technology, the company announced today. The round was led by existing investors…
